» Articles » PMID: 18331572

Specific Nasal Symptoms and Symptom-provoking Factors May Predict Increased Risk of Developing COPD

Overview
Date 2008 Mar 12
PMID 18331572
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In a 1992 questionnaire study, we found that certain nasal symptoms and symptom-provoking factors were associated with prevalence of self-reported chronic bronchitis/emphysema (CBE). In this follow-up study, we examined whether any nasal features could predict an increased incidence of self-reported physician's diagnosis of CBE/chronic obstructive pulmonary disease (COPD). In 2000, a survey was performed similar to the one in 1992. Of a paired follow-up group of 4933 participants aged 28-67 years, 4280 (86.8%) returned the questionnaire. Odds ratios (ORs) for cumulative incidence (between 1992 and 2000) of self-reported physician-diagnosed CBE/COPD and asthma, respectively, were calculated by logistic regression with adjustment for age, gender and smoking habits. Reports of thick, yellow nasal discharge and nasal blockage in 1992 predicted incidence of CBE/COPD: OR 2.3 (1.2-4.2) and 1.8 (1.1-2.8) respectively. Moreover, nasal symptoms provoked by exposure to damp/cold air and tobacco smoke predicted CBE/COPD: OR 3.4 (1.9-6.0) and 2.5 (1.4-4.2). Nasal itching and nasal symptoms provoked by exposure to grass pollen and furred animals predicted incidence of asthma. These results suggest that certain nasal symptoms and nasal symptom-provoking exposures, different from those commonly associated with asthma, may predict increased risk of developing CBE/COPD. This supports the possibility of nasal co-morbidity in COPD.

Citing Articles

Chronic Airflow Limitation, Lower Respiratory Symptoms, COPD and Chronic Rhinosinusitis in a Middle-Aged Population: The Swedish CArdioPulmonary bioImage Study (SCAPIS). A Link Between the Lower and Upper Airways.

Andersson A, Bergqvist J, Schioler L, Bossios A, Farnebo L, Holmlund T Int J Chron Obstruct Pulmon Dis. 2025; 20:273-286.

PMID: 39959845 PMC: 11829582. DOI: 10.2147/COPD.S493219.


Upper airway symptoms associate with the eosinophilic phenotype of COPD.

Obling N, Backer V, Hurst J, Bodtger U ERJ Open Res. 2021; 7(3).

PMID: 34350281 PMC: 8326684. DOI: 10.1183/23120541.00184-2021.


Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis.

Calabrese C, Costigliola A, Maffei M, Simeon V, Perna F, Tremante E Int J Chron Obstruct Pulmon Dis. 2018; 13:2025-2032.

PMID: 29988687 PMC: 6029594. DOI: 10.2147/COPD.S165857.


New evidence of increased risk of rhinitis in subjects with COPD: a longitudinal population study.

Bergqvist J, Andersson A, Olin A, Murgia N, Schioler L, Bove M Int J Chron Obstruct Pulmon Dis. 2016; 11:2617-2623.

PMID: 27799760 PMC: 5079701. DOI: 10.2147/COPD.S115086.


Allergic rhinitis in northern vietnam: increased risk of urban living according to a large population survey.

Th Lam H, Van T Tng N, Ekerljung L, Ronmark E, Lundback B Clin Transl Allergy. 2012; 1(1):7.

PMID: 22410330 PMC: 3339357. DOI: 10.1186/2045-7022-1-7.